Behavior of Troponin as a Biomarker of Myocardial Injury in Patients with End-Stage Kidney Disease Hospitalized for Sepsis
BACKGROUNDTroponin is the preferred biomarker for diagnosing acute coronary syndrome.However, in asymptomatic patients with end-stage kidney disease (ESKD), baseline elevations of troponin are common.High-sensitivity cardiac troponin I (hs-cTnI) exceeds the 99 th percentile in approximately 38% of these patients, whereas high-sensitivity cardiac troponin T is elevated in about 68%.This higher prevalence of baseline troponin elevation makes interpretation difficult during acute illness in these patients.Its prognostic significance is still uncertain in patients receiving hemodialysis. AIMTo evaluate serial plasma hs-cTnI levels and their association with short-term mortality among ESKD patients hospitalized with sepsis.
Authors
- Muhammed Mubarak (ORCID: https://orcid.org/0000-0001-6120-5884)
- Rahma Rashid (ORCID: https://orcid.org/0000-0002-9332-2644)
- Ejaz Ahmed (ORCID: https://orcid.org/0000-0003-0432-8831)
- Rubina Naqvi (ORCID: https://orcid.org/0000-0003-0666-7212)
- Sehar Qureshi
Institutions
- Sindh Institute of Urology and Transplantation (PK)
Publication Details
- Journal
- World Journal of Nephrology
- Published
- 2026-11-18
- DOI
- https://doi.org/10.5527/wjn.127146
- Primary Topic
- Acute Myocardial Infarction Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00